This user has not added any information to their profile yet.
1. Ye S, Chen Y, Huang YH, Heuck CJ, Barlogie B, Epstein J, Morgan G, Van Rhee F, Qiang YW. The Co-occurrence of MAF translocations in RAS mutated multiple myeloma Confers resistance to MEK Inhibition (manuscript preparing).
2. Ye S, Stewart JP, Ho B, Chen Y, Van Rhee F, Barlogie B, Epstein J, Shaughnessy Jr. J, Qiang YW. MMSET mediates constitutive activation of β-catenin/TCF signaling via N-cadherin in t(4;14) multiple myeloma (manuscript preparing).
3. He Y, Li W, Zhang J, Yang Y, Qiang YW, Zhou D: EF24 is highly active against chemotherapy-resistant melanoma cells by inhibiting the expression of various anti-apoptotic proteins. Current Cancer Drug Target. 2021 revised.
4. Qiang YW, Ye S, Huang Y, Chen Y, Van Rhee F, Epstein J, Walker BA, Morgan GJ, Davies FE. MAFb protein confers intrinsic resistance to proteasome inhibitors in multiple myeloma. BMC cancer. 2018 18(1):724. PMID: 29980194. PMCID: PMC6035431.
5. Yang Y, Lei H, Qiang YW, Wang B. Ixazomib enhances parathyroid hormone-induced β-catenin/T-cell factor signaling by dissociating β-catenin from the parathyroid hormone receptor. Molecular biology of the cell. 28(13):1792-1803, 2017.
6. Qiang YW, Ye S, Chen Y, Buros AF, Edmonson R, Van Rhee, F, Barlogie B, Epstein J, Morgan, GJ, Davies FE. C-maf protein mediates innate resistance to proteasome inhibition therapy in multiple myeloma. Blood. 128 : 2919-30, 2016.
7. Walker BA, Wardell CP, Murison A, Boyle EM, Begum DB, Dahir NM, Proszek PZ, Melchor L, Pawlyn C, Kaiser MF, Johnson DC, Qiang YW, Jones JR, Cairns DA, Gregory WM, Owen RG, Cook G, Drayson MT, Jackson GH, Davies FE, Morgan GJ. APOBEC family mutational signatures are associated with poor prognosis translocations in multiple myeloma. Nat Commun. 6: 6997, 2015.
8. Hu B, Chen Y, Usmani S, Ye S, Heuck C, Barlogie B, Epstein, E, Qiang YW. Characterization of molecular mechanism of carfilzomib’s bone anabolic role in multiple myeloma. PloS ONE, 8(9): e74191. doi:10.1371/journal.pone.0074191, 2013.
9. Qiang YW, Heuck CJ, Shaughnessy JD Jr, Barlogie B, Epstein J. Proteasome inhibitors and bone disease. Semin Hematol. 49:243-8, 2012.
10. Qiang YW, Chen Y, Brown N, Ho B, Epstein J, Barlogie B, and Shaughnessy JD Jr. Characterization of Wnt/ß-catenin signaling in osteoclasts in multiple myeloma. British Journal of Haematology. 148: 726-38, 2010.
11. Qiang YW, Hu B, Chen Y, Zhong Y, Shi B, Barlogie B, Shaughnessy JD Jr. Bortezomib induces osteoblast differentiation via Wnt-independent activation of ß-catenin/TCF signaling. Blood, 113: 4319-30, 2009.
12. Pinzone JJ, Hall BM, Thudi NK, Vonau M, Qiang YW, Rosol TJ, Shaughnessy JD Jr. The role of Dickkopf-1 in bone development, homeostasis, and disease. Blood,113 (3): 517-25, 2009.
13. Qiang YW, Chen Y, Stephens O, Brown B, Chen B, Epstein J, Barlogie B, and Shaughnessy JD Jr. Myeloma-derived Dickkopf-1 disrupts Wnt-regulated osteoprotegerin and RANKL production by osteoblasts: a potential mechanism underlying osteolytic bone lesions in multiple myeloma. Blood, 112(1): 196-207, 2008.
14. Qiang YW, Barlogie B, Rudikoff S and Shaughnessy JD Jr. Dkk1-induceits inhibition of Wnt signaling in osteoblast differentiation is an underlying mechanism of bone loss in multiple myeloma. Bone. 42: 669-80, 2008.
15. Qiang YW, Shaughnessy JD Jr., and Yaccoby S. Wnt3a signaling within bone inhibits multiple myeloma bone disease and tumor growth. Blood, 112(2): 374-82, 2008.
16. Qiang YW, Tian E, Zhan F, Ma Y, Barlogie, B, Rudikoff S and Shaughnessy JD Jr. The role of Wnt signaling in growth of myeloma and it interaction with marrow stroma/osteoblasts. Cytotherapy. 7:77-99, 2005
17. Qiang YW, Walsh K, Yao L, Kedei N, Blumberg P, Rubin J, Tosato G, Shaughnessy JD Jr., and Rudikoff S. Wnts induce migration and invasion of myeloma cells via activation of RhoA and PKC pathways. Blood.106: 1786-92, 2005.
18. Qiang YW, Yao L, Tosato G, Rudikoff S. Insulin-like Growth Factor I induces migration and invasion of human multiple myeloma cells. Blood. 103: 301-8, 2004.
19. Qiang YW and Rudikoff S. Insulin-like growth factor I promotes multiple myeloma cell migration and invasion. CCR Frontiers in Science. 3: 4-5, 2004.
20. Qiang YW and Rudikoff S. Wnt signaling in B and T lymphocytes. Front Biosci. 9: 1000-10, 2004.
21. Qiang YW, Endo Y, Rubin J, Rudikoff S. Wnt Signaling in B cell neoplesia. Oncogene. 22: 1536-45, 2003.
22. Qiang YW, Kopantzev Y, Rudikoff S. Insulin-like growth factor-I signaling in multiple myeloma: downstream elements, functional correlates and pathway cross talk. Blood. 99: 4138-46, 2002.
23. Qiang YW, Kitagawa M, Morihiro H, Ishii G, Morimoto C, Harigaya K. Activation of mitogen-activated protein kinase through alpha5/beta1 integrin is required for the cell cycle progression of B progenitor cell line, Reh, on stromal cells. Exp Hematol. 28: 1147-57, 2000.
24. Qiang YW, Shi B, Ishii G, Mikata A, Harigaya K. Detection of bcl-2 gene major breakpoint region rearrangement in human B-cell lymphomas. Journal of Xian Medical University. 12 (1): 5-11, 2000
25. Ishii G, Harigaya K, Qiang YW, Soeta S, Ezawa H, Yokota A, Nakamura S, Yagata H, Higashi M, Kishi H, Mikata A. Interleukin-11 gene expression in human lymphoid malignancy. Hematology. 3:143-51, 1998.
26. Ishii G, Harigaya K, Okata S, Qiang YW, Hatano M, Tokuhisa T, Mikata A. Function of IL-11 in hematopoiesis in transgenic mice. Japanese Journal of Pathology, 87: 318, 1998.
27. Harigaya K, Ishii G, Qiang YW, Mikata A. Adhesion molecules of follicular center lymphoma during tumor progression. The Journal of Japanese Society of Reticuloendothelial System, 36(5): 290-1, 1997.
28. Ishii G, Harigaya K, Nagamura S, Qiang YW, Ezawa H, Mikata A. Interleukin-11 gene expression inhuman hematopoietic and stromal cell lines. The Journal of Japanese Society of Reticuloendothelial System. 36 (2): 51, 1996.
29. Qiang YW, Shao WB, Wong QL, Wan TL, Liu Z. Study on manganese, chromium, nickel, cadmium, copper and zinc in serum and manganese, copper and zinc in blood in acute myeloid leukemia. Journal of Shanxi Leukemia. 3(3): 142-4, 1994.
30. Liu SX, Shao WB, Liu X, Qiang YW, Zhang M. Study of allogenic bone marrow transplantation in patients with acute myeloid leukemia. The Journal of Xian Medical University, 14 (1): 60-2, 1993.
31. Qiang YW, Shao WB, Wong QL, Wan TL, Liu Z. Study of manganese, chromium, nickel, cadmium, copper and zinc in multiple myeloma. Chinese Journal of Hematology. 14 (9): 481-2,1993.